Difficulty: Medium
Average Score: 94%
Practice
Treatment of cystinosis is directed at correcting the metabolic abnormalities associated with Fanconi syndrome or chronic renal failure, and the use of
Correct answer
D
Rationale
In the treatment of cystinosis, the correct answer is D) angiotensin-converting enzyme inhibitors. These medications are used to help manage hypertension that can develop as a complication of chronic renal failure, which is common in patients with cystinosis. Angiotensin-converting enzyme inhibitors work by dilating blood vessels, reducing blood pressure, and reducing the workload on the heart.
Option A) cystine eye drops are not the appropriate treatment for correcting the metabolic abnormalities associated with Fanconi syndrome or chronic renal failure in cystinosis. These eye drops are used to treat eye manifestations of cystinosis, such as corneal cystine crystal deposits.
Option B) oral cysteine is not the correct treatment either. While cysteine is a component of cystine, it is not the primary focus of treatment for the systemic metabolic abnormalities in cystinosis.
Option C) prostaglandin synthesis inhibitors are not typically used in the treatment of cystinosis. These medications are more commonly used for conditions like arthritis or to manage certain types of glaucoma.
Educationally, understanding the rationale behind the correct answer helps students grasp the importance of tailoring treatments to address specific aspects of a disease process. In pharmacology, it is crucial to select the most appropriate medication based on the underlying pathophysiology of the condition being treated. This question highlights the importance of considering comorbidities and complications when managing pediatric genitourinary disorders like cystinosis.
Option A) cystine eye drops are not the appropriate treatment for correcting the metabolic abnormalities associated with Fanconi syndrome or chronic renal failure in cystinosis. These eye drops are used to treat eye manifestations of cystinosis, such as corneal cystine crystal deposits.
Option B) oral cysteine is not the correct treatment either. While cysteine is a component of cystine, it is not the primary focus of treatment for the systemic metabolic abnormalities in cystinosis.
Option C) prostaglandin synthesis inhibitors are not typically used in the treatment of cystinosis. These medications are more commonly used for conditions like arthritis or to manage certain types of glaucoma.
Educationally, understanding the rationale behind the correct answer helps students grasp the importance of tailoring treatments to address specific aspects of a disease process. In pharmacology, it is crucial to select the most appropriate medication based on the underlying pathophysiology of the condition being treated. This question highlights the importance of considering comorbidities and complications when managing pediatric genitourinary disorders like cystinosis.